Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Trinity Biotech PLC TRIB

Healthcare Medical Devices
Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and... see more

Recent & Breaking News (NDAQ:TRIB)

Trinity Biotech Announces Q3 2024 Financial Results

GlobeNewswire November 15, 2024

Trinity Biotech to Announce Q3 2024 Financial Results

GlobeNewswire November 14, 2024

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire November 7, 2024

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

GlobeNewswire October 25, 2024

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

GlobeNewswire October 25, 2024

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

GlobeNewswire October 7, 2024

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

GlobeNewswire September 24, 2024

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

GlobeNewswire September 18, 2024

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

GlobeNewswire September 9, 2024

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

GlobeNewswire September 3, 2024

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

GlobeNewswire August 26, 2024

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

GlobeNewswire August 20, 2024

Trinity Biotech Announces Q2 2024 Financial Results

GlobeNewswire August 14, 2024

Trinity Biotech to Announce Q2 2024 Financial Results

GlobeNewswire August 13, 2024

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

GlobeNewswire August 6, 2024

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

GlobeNewswire August 2, 2024

Trinity Biotech Announces Appointment of A New CFO

GlobeNewswire July 9, 2024

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

GlobeNewswire June 24, 2024

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

GlobeNewswire June 10, 2024

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

GlobeNewswire June 3, 2024